Genedata announced a collaboration with Bayer Pharma to develop a new workflow management system to support the automation of the Cell Line Development (CLD) process for mammalian cells used to produce biopharmaceuticals.
Genedata's new CLD Data Platform is an enterprise software system that boosts the efficiency of cell line and process development and increases process quality.
Searching for more deal information? Current Partnering offers the following options:
|
It tracks all clones produced and screened in high-throughput mode, collects all relevant characterization data, such as productivity and quality parameters, and streamlines high-throughput workflows by interfacing with automation equipment such as pipetting robots, measurement devices, and bioreactors.
The CLD Data Platform enables a seamless and smooth generation of GMP-ready cell lines and their transfer into process development.
For further deal information visit Current Agreements (subscription required)
Related
Scorecard: Top partnering deals by value in 2015
View: Top pharmaceutical companies
View: Top biotech companies
Reports: Browse our extensive deal making report portfolio
